News from CMHC: Braunwald’s keynote address, sleep and CV outcomes and more

Healio and Cardiology Today have aggregated a list of the most-read articles from the virtual Cardiometabolic Health Congress.

Readers were most interested in ‘fitness vs. fatness’ and the obesity paradox, a keynote speech on advances in cardiometabolic care, the worsening of racial and ethnic disparities due to the pandemic and more.

‘Fitness vs. fatness’ may help explain obesity paradox in CVD survival

Cardiorespiratory fitness appears to be more important for CVD and CHD survival than weight or BMI, which may explain the existence of the obesity paradox, a speaker reported. Read more

Braunwald: ‘Striking’ advances made in cardiometabolic care

In recent years, cardiologists, endocrinologists and primary care physicians have observed marked advances in the use of genetics, artificial intelligence and SGLT2 inhibitors in cardiometabolic care, according to a keynote speech from Cardiology Today Editorial Board Member Eugene Braunwald, MD. Read more

Sleep important factor in development of long-term CV outcomes

Sleep could have a significant effect on CV health and long-term CV outcomes, and factors such as obstructive sleep apnea and sleep duration may warrant consideration among patients with hypertension, a speaker reported. Read more

Racial, ethnic health disparities, already prevalent, growing worse due to COVID-19

Health equity and acknowledgment of disparities among Black and Hispanic individuals is of paramount concern, especially amid the COVID-19 pandemic, according to a speech from Cardiology Today Editorial Board Member Keith C. Ferdinand, MD, FACC, FAHA, FASPC. Read more

Physical activity volume, motivation key to maintaining weight loss post-obesity

Providers should focus on the volume of physical activity performed by individuals with obesity and motivate them to get the most success in maintaining weight loss, according to a speaker. Read more

Larger dietary patterns, more so than individual factors, influence cardiometabolic health

Body weight, macronutrient distribution and sodium intake are all factors that need to be considered in the management of cardiometabolic risk factors and disease, a speaker reported. Read more

CV impact of diabetes drugs, reduction of residual risk among news highlighted at CMHC

In the past year, numerous drugs and interventions have addressed diabetes, obesity, and cardiometabolic health, a panel of speakers reported. Read more

Inflammatory hypothesis bolstered by recent trials

Over 2 decades, various research and analyses have indicated that although residual LDL and inflammation are both associated with CV risk, they should be targeted individually for optimal outcomes in secondary prevention, according to Paul M. Ridker, MD, MPH. Read more

In-person and online behavioral therapy provides additive benefits in obesity

Intensive behavioral therapy can provide additive weight-loss benefits for adults with obesity when combined with medication and diet, and online therapy could improve access to therapy at a lower cost, according to a speaker. Read more

Polypill strategy may not address underlying drivers of health disparities

The polypill approach to CVD prevention has demonstrated significant reduction in both BP and LDL levels but may fall short of addressing the larger underlying drivers of health disparities, a speaker reported. Read more